We are live on ! Find out more
SCR

SIMCERE PHARMACEUTICAL GROUP, ADS
SCR

Delisted

SCR was delisted on the 23rd of December, 2013.

Back to rankings

1 hedge funds and large institutions have $26.9K invested in SIMCERE PHARMACEUTICAL GROUP, ADS in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AIC
Archer Investment Corporation
Indiana
+$26.9K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AIC
1
Archer Investment Corporation
Indiana
$26.9K +$26.9K +1,000 New

SCR Hedge Fund Activity: Q1 2021 in Review

1 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) for Q1 2021, worth a combined $26.9K.

Buyers outnumbered sellers: 1 fund opened new SCR positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Archer Investment Corporation, opening a new position worth an estimated $26.9K.

  • 1 institutional investor held SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $26.9K of SIMCERE PHARMACEUTICAL GROUP, ADS stock for Q1 2021.
  • 1 fund opened new SIMCERE PHARMACEUTICAL GROUP, ADS positions in Q1 2021 and 0 closed out, a net change of +1 holder.
  • The largest SIMCERE PHARMACEUTICAL GROUP, ADS buyer in Q1 2021 was Archer Investment Corporation, an estimated $26.9K added.

Based on aggregated 13F filings for Q1 2021.